Antacids may improve blood sugar control in people with diabetes
2021-06-25
(Press-News.org) WASHINGTON--Antacids improved blood sugar control in people with diabetes but had no effect on reducing the risk of diabetes in the general population, according to a new meta-analysis published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Type 2 diabetes is a global public health concern affecting almost 10 percent of people worldwide. Doctors may prescribe diet and lifestyle changes, diabetes medications, or insulin to help people with diabetes better manage their blood sugar, but recent data points to common over the counter antacid medicines as another way to improve glucose levels.
"Our research demonstrated that prescribing antacids as an add-on to standard care was superior to standard therapy in decreasing hemoglobin A1c (HbA1c) levels and fasting blood sugar in people with diabetes," said study author Carol Chiung-Hui Peng, M.D., of the University of Maryland Medical Center Midtown Campus in Baltimore, Md.
"For people without diabetes, taking antacids did not significantly alter their risk of developing the disease," said study author, Huei-Kai Huang M.D., of the Hualien Tzu Chi Hospital in Hualien, Taiwan.
The researchers performed a meta-analysis on the effects of proton pump inhibitors (PPIs)--a commonly used type of antacid medication--on blood sugar levels in people with diabetes and whether these medications could prevent the new onset of diabetes in the general population. The analysis included seven studies (342 participants) for glycemic control and 5 studies (244, 439 participants) for risk of incident diabetes. The researchers found antacids can reduce HbA1c levels by 0.36% in people with diabetes and lower fasting blood sugar by 10 mg/dl based on the results from seven clinical trials. For those without diabetes, the results of the five studies showed that antacids had no effect on reducing the risk of developing diabetes.
"People with diabetes should be aware that these commonly used antacid medications may improve their blood sugar control, and providers could consider this glucose-lowering effect when prescribing these medications to their patients," said study author Kashif Munir, M.D., associate professor in the division of endocrinology, diabetes and nutrition at the University of Maryland School of Medicine in Baltimore, Md.
INFORMATION:
Other authors of the study include: Yuting Huang and Khulood Bukhari of the University of Maryland Medical Center Midtown Campus in Baltimore, Md.; Yu-Kang Tu of the National Taiwan University and the Taipei Medical University in Taipei, Taiwan; Gin Yi Lee of the Danbury Hospital in Danbury, Conn.; Rachel Huai-En Chang of the Johns Hopkins Bloomberg School of Public Health in Baltimore, Md.; Yao-Chou Tsai of the Taipei Medical University; Yunting Fu of the University of Maryland in Baltimore, Md.
The manuscript received no external funding.
The manuscript, "Effects of Proton Pump Inhibitors on Glycemic Control and Incident Diabetes: A Systematic Review and Meta-analysis," was published online, ahead of print.
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.
ELSE PRESS RELEASES FROM THIS DATE:
2021-06-25
What The Study Did: This study evaluated changes in hospitalization and death rates related to COVID-19 before and after U.S. states reopened their economies in 2020.
Authors: Pinar Karaca-Mandic, Ph.D., of the Carlson School of Management in Minneapolis, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamahealthforum.2021.1262)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
INFORMATION:
Media advisory: The full study ...
2021-06-25
What The Study Did: Researchers examined the association of closures of childcare facilities with the employment status of women and men with children in the United States during the COVID-19 pandemic.
Authors: Yevgeniy Feyman, B.A., of the Boston University School of Public Health, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamahealthforum.2021.1297)
Editor's Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author ...
2021-06-25
What The Study Did: This analysis describes the use of a multifaceted COVID-19 control plan to reduce spread of SARS-CoV-2 at a large urban university during the second wave of the pandemic.
Authors: Davidson H. Hamer, M.D., of the Boston University School of Public Health, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.16425)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and ...
2021-06-25
What The Study Did: Researchers looked at whether age-related hearing impairment among older adults is associated with poorer and faster decline in physical function and reduced walking endurance.
Authors: Pablo Martinez-Amezcua, M.D., Ph.D., M.H.S., of the Johns Hopkins Bloomberg School of Public Health in Baltimore, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.13742)
Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
INFORMATION:
Media ...
2021-06-25
Scientists of Tomsk Polytechnic University jointly with their colleagues have synthetized a unique molecule of verdazyl-nitronyl nitroxide triradical. Only several research teams in the world were able to obtain molecules with similar properties. The molecule is stable. It is able to withstand high temperatures and obtains promising magnetic properties. It is a continuation of scientists' work on the search for promising organic magnetic materials. The research findings are published in the Journal of the American Chemical Society (IF: 14.612, Q1).
Magnetoresistive random-access memory (MRAM) is one of the most promising technologies for storage devices. ...
2021-06-25
CHAPEL HILL, NC - When we think of the brain, we think of neurons. But much of the brain is made of non-neuronal cells called glial cells, which help regulate brain development and function. For the first, time UNC School of Medicine scientist Katie Baldwin, PhD, and colleagues revealed a central role of the glial protein hepaCAM in building the brain and affecting brain function early in life.
The findings, published in Neuron, have implications for better understanding disorders, such as autism, epilepsy, and schizophrenia, and potentially for creating therapeutics for conditions such as the progressive brain disorder megalencephalic ...
2021-06-25
TAMPA, Fla. -- E-cigarettes spark many concerns, especially when it comes to youth vaping. However, emerging evidence suggests that e-cigarettes can be a helpful tool in smoking cessation. Researchers in Moffitt Cancer Center's Tobacco Research and Intervention Program wanted to build upon this evidence by testing whether they could help dual users, people who use both combustible cigarettes and e-cigarettes, quit smoking. In a new article published in The Lancet Public Health, they report results from a first-of-its kind nationwide study evaluating a targeted intervention aimed at transforming dual users' e-cigarettes from a product that might ...
2021-06-25
CHAPEL HILL, NC - Developing a viable vaccine against dengue virus has proved difficult because the pathogen is actually four different virus types, or serotypes. Unless a vaccine protects against all four, a vaccine can wind up doing more harm than good.
To help vaccine developers overcome this hurdle, the UNC School of Medicine lab of Aravinda de Silva, PhD, professor in the UNC Department of Microbiology and Immunology, investigated samples from children enrolled in a dengue vaccine trial to identify the specific kinds of antibody responses that correlate with ...
2021-06-25
UPTON, NY--Scientists have organized proteins--nature's most versatile building blocks--in desired 2-D and 3-D ordered arrays while maintaining their structural stability and biological activity. They built these designer functional protein arrays by using DNA as a programmable construction material. The team--representing the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, Columbia University, DOE's Lawrence Berkeley National Laboratory, and City University of New York (CUNY)--described their approach in the June 17 issue of Nature Communications.
"For decades, scientists have dreamed about rationally assembling proteins into specific organizations with preserved protein function," ...
2021-06-25
Scientists from within the Antibody and Vaccine Group at the University of Southampton have gained novel insights into how an important class of immune receptors called tumour necrosis factor receptors (TNFR) are activated.
The work, published in the journal Communications Biology, investigates a class of receptors present on immune cells called TNFR. These receptors, such as CD40, 4-1BB and OX40, are key in helping the immune system fight pathogens and cancer cells. Accordingly, antibody drugs which are designed to specifically target and activate these receptors (called ...
LAST 30 PRESS RELEASES:
[Press-News.org] Antacids may improve blood sugar control in people with diabetes
